Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Giulio Cavalli, Alessandro Tomelleri, Giacomo De Luca, Corrado Campochiaro, Charles A. Dinarello, Elena Baldissera, Loreno Dagna

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number54
JournalArthritis Research and Therapy
Issue number1
Publication statusPublished - Feb 13 2019

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this